Form 4: Adaptive Biotechnologies Director Michelle Griffin Sells Shares
SEC Form 4
Director Michelle Griffin sold 36,291 shares of Adaptive Biotechnologies Corp (ADPT) at an average price of $7.19 on March 13, 2025.
Summary
- On March 13, 2025, Michelle Renee Griffin, a director of Adaptive Biotechnologies Corp (ADPT), sold 36,291 shares of common stock.
- The sale was executed at a weighted-average price of $7.19 per share, with individual transactions ranging from $7.15 to $7.25.
- Following the transaction, Griffin directly owns 15,394 shares of Adaptive Biotechnologies Corp.
- The transaction was reported on a Form 4 filing with the Securities and Exchange Commission.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a standard disclosure of an insider stock sale. The size of the sale is not significant enough to drastically alter sentiment.
Industry Context
This is a routine disclosure of an insider transaction. It's important to monitor insider activity as it can provide insights into management's perspective on the company's valuation and future prospects. However, one sale does not necessarily indicate a negative outlook.
Stakeholder Impact
- The sale of shares by a director could potentially create short-term uncertainty among shareholders.
Key Dates
| Date | Description |
|---|---|
| 03/13/2025 | Date of the transaction (sale of shares) |
| 03/17/2025 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.